Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock

Critical Care Clinics

Volumn 16, Issue 2, 2000, Pages 289-317

  Fein, Alan M ^a,b   Calalang Colucci, Mylene G ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; LUNG INJURY; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0034107472     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70111-1     Document Type: Article

References (122)

1. E. Abraham A. Anzueto G. Gutierrez Double-blind, randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock Lancet 351 1998 929 933
2. M.B.P. Amato C.S. Barbas D.M. Medeiros Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome Am J Respir Crit Care Med 152 1995 1835 1846
3. M.B.P. Amato C.S. Barbas D.M. Medeiros Effect of a protective ventilation strategy on mortality in the acute respiratory distress syndrome N Engl J Med 338 1998 347 354
4. A. Anzueto R.P. Baughman K.K. Guntupalli Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome N Engl J Med 334 1996 1417 1421
5. A. Artigas G.R. Bernard J. Carlet The American-European Consensus Conference on ARDS, Part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling Intsive Care Med 24 1998 378 398
6. D.G. Ashbaugh D.B. Bigelow T. Petty Acute respiratory distress syndrome in adults Lancet 2 1967 319 323
7. R.C. Bell J.J. Coalson J.D. Smith Multiple-organ system failure and infection in the adult respiratory distress syndrome Ann Intern Med 99 1983 293 298
8. G.R. Bernard A. Artigas K.L. Brigham The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination Am J Respir Crit Care Med 149 1994 818 824
9. L. Blanch J. Mancebo M. Martinez Short term effects of prone position in critically ill patients with acute respiratory distress syndrome Intensive Care Med 23 1997 1033 1039
10. R.C. Bone Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation Crit Care Med 24 1996 163 172
11. R.C. Bone R. Balk F.B. Cerra Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Chest 101 1992 644 655
12. R.C. Bone C.J. Fischer T.P. Clemmer Sepsis syndrome: A valid clinical entity Crit Care Med 17 1989 389 393
13. A. Bryan Comments of a devil's advocate Am Rev Respir Dis 110 1974 143S 144S
14. T.M. Carlos J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101
15. G. Chatte J.M. Sab J.M. Dubois Prone position in mechanically ventilated patients with severe acute respiratory failure Am J Respir Crit Care Med 155 1997 473
16. S. Chollet-Martin P. Montravers C. Gilbert High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome Infect Immunol 61 1993 4553 4559
17. K.G. Connelly J.E. Repine Markers for predicting the development of acute respiratory distress syndrome Ann Rev Med 48 1997 429 445
18. H.G. Cowley D. Heney A. Gearing Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study Crit Care Med 22 1994 651 657
19. R.L. Danner R.J. Elin J.M. Hosseini Endotoxemia in human septic shock Chest 99 1991 169 175
20. T.A. Davidson E.S. Caldwell J.R. Curtis Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients JAMA 281 1999 354 360
21. R.P. Dellinger J.L. Zimmerman R.W. Taylor Placebo and inhaled nitric oxide mortality the same in ARDS clinical trial: Results of randomized phase II trial Crit Care Med 26 1998 619
22. J.E. Dematte M.L. Barnard J.I. Sznajder Acute respiratory failure in sepsis Fein A.M. Abraham E.M. Sepsis and Multiorgan Failure 1997 Williams & Wilkins Baltimore
23. S.C. Donnelly C. Haslett I. Dransfield Mechanisms of the adult respiratory distress syndrome: Selectins Thorax 50 1995 S49 S52
24. S.C. Donnelly C. Haslett I. Dransfield Role of selectins in development of adult respiratory distress syndrome Lancet 344 1994 215 219
25. G.P. Downey L. Fialkow T. Fukushima Initial interaction of leukocytes within the mirovasculature: Deformability, adhesion, transmigration New Horizons 3 1995 219 228
26. G.P. Downey J.T. Granton Mechanisms of acute lung injury Curr Opin Crit Care 3 1997 43 50
27. R.L. Doyle N. Szaflarski G.W. Modin Identification of patients with acute lung injury Am Rev Respir Dis 152 1995 1818 1824
28. D. Dreyfuss P. Soler G. Basset High inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure Am Rev Respir Dis 137 1988 1159 1164
29. A.M. Fein R.F. Grossman E. Jones The value of edema fluid protein measurement in patients with pulmonary edema Am J Med 67 1979 32 38
30. A.M. Fein M. Lippman H. Holtzman The risk factors, incidence and prognosis of ARDS following Septicemia Chest 83 1983 40 42
31. M. Ferring J.L. Vincent Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J 10 1997 1297 1300
32. C.J. Fischer J.F.A. Dhainaut S.M. Opal Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double blind, placebo-controlled trial JAMA 271 1994 1836 1843
33. H. Flatten S. Aardal O. Hevrøy Improved oxygenation using the prone position in patients with ARDS Acta Anaesthesiol Scand 42 1998 329 334
34. A.A. Fowler R.F. Hamman J.T. Good Adult respiratory distress syndrome: Risks with common predispositions Ann Intern Med 98 1983 593 597
35. A.A. Fowler R.F. Hamman G.O. Zerbe Adult respiratory distress syndrome, prognosis after onset Am Rev Respir Dis 132 1985 472 478
36. C.G. Frostell M.D. Fratacci J.C. Wain Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction Circulation 83 1991 2038 2047
37. C.G. Frostell H. Blomquist G. Hedenstierna Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation Anesthesiology 78 1993 427 435
38. L. Gattinoni P. Pelosi G. Vitale Body position changes redistribute lung computed tomographic density in patients with acute respiratory failure Anesthesiology 74 1991 15 23
39. A. Ghio G. Elliot R. Crapo Impairment after adult respiratory syndrome Am Rev Respir Dis 139 1989 1158 1162
40. R.B. Goodman R. Strieter D.P. Martin Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome Am J Respir Crit Care Med 154 1996 602 611
41. E. Troncy J.P. Collet S. Shapiro Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study Am J Respir Crit Care Med 157 1998 1483 1488
42. D. Guidot M. Moss F. Holguin Alveolar ingestion impairs alveolar epithelial glutathione homeostasis and function, and predisposes to endotoxin-mediated acute lung injury Chest 116 1999 82S
43. A.S. Headley E. Tolley G.U. Meduri Infections and the inflammatory response in acute respiratory distress syndrome Chest 111 1997 1306 1321
44. C. Hormann H. Benzer M. Baum The prone position in ARDS: A successful strategy Anaesthesist 43 1994 454
45. L.D. Hudson J.A. Milberg D. Anardi Clinical risks for development of the acute respiratory distress syndrome Am Rev Respir Dis 151 1995 293 301
46. H. Humprey J. Hall I. Sznajder Improved survival in ARDS patients associated with a reduction in the pulmonary capillary wedge pressure Chest 97 1990 1176 1180
47. T.M. Hyers Prediction of survival and mortality in patients with adult respiratory distress syndrome New Horizons 1 1993 466 470
48. M. Hyers S.M. Tricomi P.A. Dettenmeier Tumor necreosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome Am Rev Respir Dis 144 1991 268 271
49. P. Jolliet P. Bulpa M. Ritz Additive beneficial effects of the prone position, nitric oxide and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome Crit Care Med 25 1997 786
50. T. Kawano S. Mori M. Cybulsky Effect of granulocyte depletion in a ventilated surfactant-depleted lung J Appl Physiol 62 1987 27 33
51. W.A. Knaus X. Sun R.B. Hakim Evaluation of the definitions for adult respiratory distress syndrome Am J Respir Crit Care Med 150 1994 311 317
52. P. Krafft P. Fridrich R.D. Fitzgerald Effectiveness of nitric oxide Inhalation in septic ARDS Chest 109 1996 486 493
53. M. Langer D. Mascheroni R. Marcolin The prone position in ARDS patients: A clinical study Chest 94 1988 103
54. P.F. Langlois M.S. Gawryl Accentuated formation of the terminal C5b-9 complement complex in plasma preceded development of the adult respiratory distress syndrome Am Rev Respir Dis 138 1988 368 375
55. J.M. Luce Acute lung injury and the acute respiratory distress syndrome Crit Care Med 26 1998 369 376
56. J.M. Luce A.B. Montgomery J.D. Marks Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock Am Rev Respir Dis 138 1988 62 68
57. S. Lundin H. Mang M. Smithies Inhalation of nitric oxide in acute lung injury: Preliminary results of a European multicenter study Intensive Care Med 23 1998 2S
58. J.J. Marini A lung protective approach to ventilating ARDS Resp Care Clin 4 1998 633 663
59. J.D. Marks C.B. Marks J.M. Luce Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome and effects of methylprednisolone administration Am Rev Respir Dis 141 1990 94 97
60. C. Martin C. Boisson M. Haccoun Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma Crit Care Med 25 1997 1813 1819
61. M.A. Martin H.J. Silverman Gram-negative sepsis and the adult respiratory distress syndrome Clin Infect Dis 14 1992 1213 1228
62. M.A. Martin R.P. Wenzel K.J. Gorelick Prospective U.S. study of gram-negative bacterial sepsis: Natural history in the 1980's Circ Shock 31 1990 245 Abstract 0–12
63. T.M. Martin Lung cytokines and ARDS Chest 116 1999 2S 8S
64. T.R. Martin B.P. Pistonese L.D. Hudson Function of lung and blood neutrophils in patients with the adult respiratory distress syndrome: Implications for the pathogenesis of lung infections Am Rev Resp Dis 144 1991 254 262
65. M. Mathru M.W. Rooney D.J. Dries Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis Chest 105 1994 232 236
66. M. Matthay W.L. Eschenbacher E.J. Goetzl Elevated concentration of leukotrienes D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome J Clin Immunol 4 1984 479 483
67. L.G. McHugh J.A. Milberg M.E. Whitcomb Recovery of function in survivors of the acute respiratory distress syndrome Am J Respir Crit Care Med 150 1994 90 94
68. G.U. Meduri A.J. Chinn K.V. Leeper Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: Patterns of response and predictors of outcome Chest 105 1994 1516 1527
69. U.G. Meduri S. Headley E. Golden Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome JAMA 280 1998 159 165
70. G.U. Meduri S. Headley G. Kohler Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS Chest 107 1995 1062 1073
71. G.U. Meduri S. Headley E. Tolley Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS Chest 108 1995 1315 1325
72. G.U. Meduri G. Kohler S. Headley Inflammatory cytokines in the BAL of patients with ARDS: Persistent elevation overtime predicts poor outcome Chest 108 1995 1303 1314
73. U.G. Meduri E. Tolley A. Chinn Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment Am J Respir Crit Care Med 158 1998 1432 1441
74. J.A. Milberg D.R. Davis K. Steinberg Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993 JAMA 273 1995 306 309
75. A.B. Millar N.M. Foley M. Singer Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome Lancet 2 1989 712 714
76. E.J. Miller A.B. Cohen D. Griffith Elevated levels of NAP-1/Interleukin-8 are present in the air spaces of patients with the adult respiratory distress syndrome and are associated with increased mortality Am Rev Respi Dis 146 1992 427 432
77. J.P. Mitchell D. Schuller F.S. Calandrino Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization Am Rev Respir Dis 145 1992 990 998
78. B.A. Montgomery M.A. Stager J. Carrico Causes of mortality in patients with the adult respiratory distress syndrome Am Rev Respir Dis 132 1985 485 491
79. M. Moss B. Bucher F.S. Moore The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults JAMA 275 1996 50 54
80. M. Moss M.K. Gillespie L. Ackerson Endothelial cell activity in patients at risk for the adult respiratory distress syndrome Crit Care Med 24 1996 1782 1786
81. M. Moss P.L. Goodman M. Heinig Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome Crit Care Med 23 1995 1629 1637
82. J.F. Murray M.A. Matthay J.M. Luce An expanded definition of the adult respiratory distress syndrome Am Rev Respir Dis 138 1988 720 723
83. M.S. Niederman A.M. Fein Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: A common clinical sequence Clin Chest Med 11 1990 633 656
84. P. Pelosi D. Tubiolo D. Mascheroni Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury Am J Respir Crit Care Med 156 1998 387
85. P.E. Pepe R.T. Potkin D.H. Reus Clinical predictors of the adult respiratory distress syndrome Am J Surg 144 1982 125 129
86. G.W. Petersen H. Baier Incidence of pulmonary barotrauma in a medical ICU Crit Care Med 11 1983 67 69
87. M.A. Piehl R.S. Brown Use of extreme position changes in respiratory failure Crit Care Med 4 1976 13 14
88. J.F. Pittet C. Mackersie T.R. Martin Biological markers of acute lung injury: Prognostic and pathogenetic significance Am J Respir Crit Care Med 155 1997 1187 1205
89. J. Pugin B. Ricou K.P. Steinberg Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS: A prominent role for interleukin-1 Am J Respir Crit Care Med 153 1996 1850 1856
90. G.J. Quinlan N.J. Lamb R. Tilley Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity and mortality Am J Respir Crit Care Med 155 1997 479 484
91. M.S. Rangel-Frausto D. Pittet M. Costigan The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study JAMA 273 1995 117 123
92. V.M. Ranieri L. Mascia T. Fiore Cardiorespiratory effects of positive end expiratory pressure during progressive tidal volume reduction in patients with acute respiratory distress syndrome Anesthesiology 83 1995 710
93. V.M. Ranieri P.M. Suter C. Tortorella Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial JAMA 282 1999 54 61
94. P.C. Ridings A.C.J. Windsor M.A. Jutila A dual-binding monoclonal antibody to E- and L-selectin attenuates sepsis-induced lung injury Am J Respir Crit Care 152 1995 247 253
95. J.E. Rinaldo J.W. Christman Acute respiratory distress syndrome: Pathogenesis Fishman A.P. Grippi M.A. Kaiser L.R. Fishman's Pulmonary Diseases and Disorders 3rd ed 1998 McGraw-Hill New York 2537 2548
96. J.E. Rinaldo R.M. Rogers Adult respiratory distress syndrome: Changing concepts of lung injury and repair N Engl J Med 306 1982 900 909
97. R. Rossaint K.J. Falke F. Lopez Inhaled nitric oxide for the adult respiratory distress syndrome: N Engl J Med 328 1993 399 405
98. R. Roten M. Markert F. Feihl Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome Am Rev Respir Dis 143 1991 590 592
99. K.E. Sands D.W. Bates P.N. Lunken Epidemiology of sepsis syndrome in 8 academic medical centers JAMA 278 1997 234 240
100. D. Schuller J.P. Mitchell F.S. Candrino Fluid balance during pulmonary edema: Is fluid gain a marker or a cause of poor outcome? Chest 100 1991 1068 1075
101. H. Schütte J. Lohmeyer S. Rosseau Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary edema Eur Respir J 9 1996 1858 1867
102. C.N. Sessler Mechanical ventilation of patients with acute lung injury Crit Care Clin 14 1998 707 729
103. C.N. Sessler G.L. Bloomfield A.A. Fowler Current concepts of sepsis and acute lung injury Clin Chest Med 17 1996 213 235
104. P.J. Sloane M.H. Gee J.E. Gottlieb A multicenter registry of patients with acute respiratory distress syndrome Am Rev Respir Dis 146 1992 419 426
105. G.J. Slotman K.W. Burchard A. D'Arezzo Ketoconazole prevents acute respiratory failure in critically ill surgical patients J Trauma 28 1988 648 654
106. A.S. Slutsky Lung injury caused by mechanical ventilation Chest 116 1999 9S 15S
107. Stewart T, Meade M, Cook D, et al: Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for ARDS. N Engl J Med 338:355–361
108. R.M. Strieter S.L. Kunkel Acute lung injury: The role of cytokines in the elicitation of neutophils J Investig Med 42 1994 640 651
109. R.M. Streiter J.P. Lynch III M.A. Basha Host responses in mediating sepsis and adult respiratory distress syndrome Sem Resp Infect 5 1990 233 247
110. P.M. Suter S. Suter E. Girardin High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase in patients with adult respiratory distress after trauma, shock or sepsis Am Rev Respir Dis 145 1992 1016 1022
111. J.F. Tomashefski Pulmonary pathology of the adult respiratory distress syndrome Clin Chest Med 11 1990 593 619
112. L. Tremblay F. Valenza S.P. Ribiero Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model J Clin Invest 99 1997 944
113. D.V. Tuxen Permissive hypercapnic ventilation Am J Respir Crit Care Med 150 1994 870 874
114. S.T. Vasilyev R.N. Schaap J.D. Mortensen Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units: An international, multicenter, prospective survey Chest 107 1995 1083 1088
115. J. Villar A.S. Slutsky The incidence of the adult respiratory distress syndrome Am Rev Respir Dis 140 1989 814 818
116. J.G. Weg A. Anzueto R.A. Balk The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome N Engl J Med 338 1998 341 346
117. J.E. Weiland W.B. Davis J.R. Holter Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance Am Rev Respir Dis 133 1986 218 225
118. J.F. Weinberg M.A. Matthay R.O. Webster Biologically active products of complement and acute lung injury in patients with the sepsis syndrome Am Rev Respir Dis 130 1984 791 796
119. J.B. West O. Mathieu-Costello Stress failure of pulmonary capillaries as a limiting factor for maximal exercise Eur J Appl Physiol 70 1995 99 108
120. M. Yu G. Tomasa A double-blind, prospective, randomized trial for ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome Crit Care Med 21 1993 1635 1642
121. W.M. Zapol M.J. Frikker H. Pontopiddan The adult respiratory distress syndrome at Massachusetts General Hospital: Etiology, progression and survival rates, 1978–1988 Zapol W. LeMaire F. Adult Respiratory Distress Syndrome 1991 Marcel Dekker New York 367 380
122. E.J. Ziegler C.J. Fischer C.L. Sprung Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial N Engl J Med 324 1991 429 436